Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Efficacy and safety of dual-targeted therapy for inflammatory bowel disease: a retrospective multicenter study in China

Xiuxiu Jin, Kefang Sun, Liying Wang [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2023-03

Efficacy and Safety of Dual-Targeting Chimeric Antigen Receptor-T Therapy for Relapsed or Refractory B Cell Lymphoid Malignancies: A Systematic Review and Meta-Analysis

Min Yu, Qian Zhang, Fancong Kong [...]

Human Gene Therapy

Open access

Research article

First published 2025

Clinical relevance of circulating tumor DNA in HER2-positive advanced gastric cancer: a collaborative study of a phase Ib trial of dual HER2 and PD-1 targeted therapy (Ni-High)

Hiroki Osumi, Takeru Wakatsuki, Akira Ooki [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2024

Raising the bar in ulcerative colitis management

Fabrizio Fanizzi, Mariangela Allocca, Gionata Fiorino [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2021

Favourable outcome of patients with breast cancer brain metastases treated with dual HER2 blockade of trastuzumab and pertuzumab

Elisabeth Sophie Bergen, Amelie Binter, Angelika Martina Starzer [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Molecular features and clinical outcomes of EGFR-mutated,MET-amplified non-small-cell lung cancer after resistance to dual-targeted therapy

Mei-Mei Fang, Jiang-Tao Cheng, Yu-Qing Chen [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2017-7

Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy

Yufeng Guo, Haixing Xu, Yiping Li [...]

Journal of Biomaterials Applications

Open access

Review article

First published 2012

Is the Improved Efficacy of Trastuzumab and Lapatinib Combination Worth the Added Toxicity? A Discussion of Current Evidence,Recommendations,and Ethical Issues regarding Dual HER2-Targeted Therapy

Eugene R. Ahn, Emilie Wang, Stefan Glück

Breast Cancer: Basic and Clinical Research

Retricted access

Research article

First published 2019

Analysis of the Authorized Target Populations for Fixed Dose Combination Products Between 2000 and 2017 Reveals Discrepancies Between EMA’s and FDA’s Views on Initial Dual-Therapy

Ole Jannik Bjerrum, Sascha Eichendorff, Nada Bassam Alkis

Therapeutic Innovation & Regulatory Science

Open access

Review article

First published 2021

Novel trends with biologics in inflammatory bowel disease: sequential and combined approaches

Giuseppe Privitera, Daniela Pugliese, Loris Riccardo Lopetuso [...]

Therapeutic Advances in Gastroenterology

Search results